Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

INTRAMEDIC HOLDING A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.6% 2.2% 1.9% 2.0% 0.9% 1.1% 8.1% 8.1%   Credit score (0-100)   76 68 70 67 90 82 30 30   Credit rating   A BBB A A A A BB BB   Credit limit (kDKK)   24.2 0.2 4.8 1.9 1,666.5 666.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -34.4 -1,485 -395 -954 -258 -329 0.0 0.0   EBITDA   -34.4 -1,485 -395 -954 -258 -329 0.0 0.0   EBIT   -34.4 -1,485 -395 -954 -258 -329 0.0 0.0   Pre-tax profit (PTP)   9,547.5 5,415.4 13,000.6 12,410.7 4,724.0 8,545.7 0.0 0.0   Net earnings   9,600.6 5,500.7 13,154.8 12,676.2 4,638.7 8,516.4 0.0 0.0   Pre-tax profit without non-rec. items   9,548 5,415 13,001 12,411 4,724 8,546 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   11,737 7,752 18,292 17,614 20,221 18,592 8,092 8,092   Interest-bearing liabilities   11,079 10,745 9,297 9,908 7,251 4,448 0.0 0.0   Balance sheet total (assets)   25,532 22,258 30,671 31,636 29,955 23,789 8,092 8,092   Net Debt   10,945 10,183 9,207 9,907 2,993 3,377 -8,092 -8,092     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -34.4 -1,485 -395 -954 -258 -329 0.0 0.0   Gross profit growth   -11.6% -4,221.1% 73.4% -141.2% 72.9% -27.1% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   25,532 22,258 30,671 31,636 29,955 23,789 8,092 8,092   Balance sheet change%   12.4% -12.8% 37.8% 3.1% -5.3% -20.6% -66.0% 0.0%   Added value   -34.4 -1,485.4 -395.3 -953.5 -258.5 -328.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   40.8% 24.1% 50.5% 40.7% 15.9% 32.6% 0.0% 0.0%   ROI %   45.4% 27.9% 58.0% 46.0% 17.8% 34.6% 0.0% 0.0%   ROE %   91.7% 56.4% 101.0% 70.6% 24.5% 43.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   46.0% 34.8% 59.6% 55.7% 67.5% 78.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -31,841.4% -685.5% -2,329.0% -1,039.0% -1,158.1% -1,027.8% 0.0% 0.0%   Gearing %   94.4% 138.6% 50.8% 56.2% 35.9% 23.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.6% 3.3% 3.6% 2.8% 2.0% 3.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.2 0.1 0.4 0.5 0.9 0.8 0.0 0.0   Current Ratio   0.2 0.1 0.4 0.5 0.9 0.8 0.0 0.0   Cash and cash equivalent   133.9 561.9 90.0 0.4 4,258.1 1,071.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -11,600.6 -12,391.1 -7,778.7 -5,877.2 -659.0 -876.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0